Author

G. Shapira

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

N. Shomron· 2 shared A. Gutwillig· 1 shared A. Madi· 1 shared C. Luxenburg· 1 shared D. Levy· 1 shared D. Rasoulouniriana· 1 shared E. Abayev· 1 shared E. D. Levy· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

N. Shomron

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structure-function conservation between the methyltransferases SETD3 and SETD6

D. Levy, L. Elisha, E. Abayev, O. Cohn, G. Shapira, N. Shomron, M. Feldman

The paper identifies shared and distinct functions of SETD3 and SETD6 in apoptosis regulation through proteomic and RNA-seq analyses of knockout cells.

bioRxiv · Mar 31, 2022Cell Biology

Mutants libraries reveal negative design shielding proteins from mis-assembly and re-localization in cells

H. Garcia-Seisdedos, T. Levin, G. Shapira, S. Freud, E. D. Levy

The paper shows that surface mutations in homo-oligomeric proteins often cause mislocalization and misassembly, revealing negative design that shields against these effects.

bioRxiv · Jan 20, 2021Biophysics

Transient cell-in-cell formation underlies tumor resistance to immunotherapy

A. Gutwillig, N. Santana-Magal, L. Farhat-Younis, D. Rasoulouniriana, A. Madi, C. Luxenburg, J. Cohen, K. Padmanabhan, N. Shomron, G. Shapira, M. Feinmesser, O. Zlotnik, R. Debets, N. E. Reticker-Flynn, P. Rider, Y. Carmi

This study identifies transient cell-in-cell formations as a mechanism enabling tumor resistance to immunotherapy, showing they protect tumor cells from immune and chemotherapy attacks.

bioRxiv · Sep 10, 2020 · PreprintImmunology